GlassScriptPhysician profile
Heather A Dawson
NPI 1265088199
$5,657.41
in general payments reported to CMS, 2019-2025
14 companies · $38.83 in 2025
The $38.83 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,228 · 2022: $989 · 2023: $1,801 · 2024: $1,601 · 2025: $38.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,441.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,440.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $755.76 | 2021-2024 | Abilify Maintena, Rexulti |
| Alkermes, INC. | $755.12 | 2021-2025 | Aristada, Lybalvi, Aristada Initio |
| Teva Pharmaceuticals USA, INC. | $718.19 | 2021-2024 | Austedo Xr, Uzedy, Austedo |
| Janssen Pharmaceuticals, INC | $636.45 | 2021-2024 | Invega Sustenna, Spravato, Invega Trinza |
| Abbvie INC. | $590.24 | 2021-2024 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $580.10 | 2021-2024 | Caplyta |
| Otsuka America Pharmaceutical, INC. | $557.42 | 2021-2024 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Supernus Pharmaceuticals, INC. | $351.49 | 2023-2024 | Qelbree, Qelbree |
| Indivior INC. | $265.77 | 2021-2024 | Perseris |
| Vanda Pharmaceuticals INC. | $125.99 | 2021-2025 | Fanapt, Hetlioz |
| Regeneron Healthcare Solutions, INC. | $114.75 | 2023 | Libtayo |
| Neurocrine Biosciences, INC. | $99.75 | 2023-2024 | Ingrezza |
| Takeda Pharmaceuticals U.S.A., INC. | $60.42 | 2021 | |
| Noven Therapeutics, LLC | $45.96 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Dawson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.